2013-12-27T13:04:59-06:00 2013-03-31 ERNST & YOUNG US LLP 1901 SIXTH AVE NORTH STE 1200 BIRMINGHAM AL 35203 990 2012-04-01 751835298 SUSAN G KOMEN BREAST CANCER FOUNDATION INC % Mark Nadolny CFO SUSA 9728551600 5005 LBJ Freeway Suite 250 Dallas TX 752446125 Mark Nadolny 2013-12-27 2052541608 2012 2015-11-30 17:44:51Z SUSAN G KOMEN FOR THE CURE DrJudith Salerno CEOPRESIDNT 5005 LBJ Freeway Suite 250 Dallas TX 752446125 182276852 false 7164 X www.komen.org X 1982 TX TO END BREAST CANCER BY FUNDING RESEARCH AND HEALTH PROGRAMS FOCUSED ON EDUCATION, SCREENING/TREATMENT AND SUPPORT PRIMARILY AIMED AT THE MEDICALLY UNDERSERVED IN THE U.S AND 30 COUNTRIES. 10 9 320 5675 0 0 159779664 118656952 33193701 26281480 7951630 7368340 -3836540 -5984835 197088455 146321937 71697843 49882918 0 0 26312020 25941318 1160108 1598294 20118107 89188244 82440666 188358215 159863196 8730240 -13541259 313104320 294589250 193001246 175912920 120103074 118676330 X TO END BREAST CANCER BY FUNDING RESEARCH AND HEALTH PROGRAMS FOCUSED ON EDUCATION, SCREENING/TREATMENT AND SUPPORT PRIMARILY AIMED AT THE MEDICALLY UNDERSERVED IN THE U.S AND 30 COUNTRIES. false false 53120881 41380728 26281480 Grants to other charitable organizations to support research and clinical investigation of breast cancer. See schedule O for additional details. 64057427 3273047 274466 Public health education programs to increase the public's awareness of breast cancer including, among other things, detection and treatment. See schedule O for additional details. 13862971 5229143 0 Health treatment and screening programs and grants. See schedule O for additional details. 131041279 true true false true false false false false false true true false false false false true false true false false true true false true true false false true false true false false false false false false false false true false false false false false false false false true 234 0 true 320 true false true IS false false false true true false false false false X 10 9 false false true false false false false true true false true true true true true true true true true true false AL AK AZ AR CA CO CT DC DC FL GA HI IL IN KS KY ME MD MA MI MN MS MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT UT VA WA WV WI X X Mark Nadolny CFO 9728551600 5005 LBJ Freeway Suite 250 Dallas TX 752446125 Robert C Taylor 1.0 0.0 X 0 0 0 Linda Custard 1.0 0.0 X 0 0 0 Jane Abraham 1.0 0.0 X 0 0 0 Elyse Gellerman 1.0 0.0 X 0 0 0 Connie O'Neill 1.0 0.0 X X 0 0 0 John D Raffaelli 1.0 0.0 X 0 0 0 Tricia Ory 1.0 0.0 X 0 0 0 Dr LaSalle LeFall 1.0 0.0 X 0 0 0 Linda Law 1.0 0.0 X X 0 0 0 Alan D Feld 1.0 0.0 X 0 0 0 Brenda Lauderback 1.0 0.0 X 0 0 0 Dr Olofunmlayo Olopade 1.0 0.0 X 0 0 0 Nancy G Brinker 55.0 0.0 X X 560896 0 23739 Ellen Willmott 55.0 0.0 X 141415 0 4180 Lesley Lurie 55.0 0.0 X 181205 0 26651 Elizabeth Thompson 55.0 0.0 X 606461 0 26052 Katrina McGhee 55.0 0.0 X 120941 0 13157 Mark Nadolny 55.0 0.0 X 307664 0 31464 David Dawson 55.0 0.0 X 208675 0 29985 Chandini Portteus 55.0 0.0 X 197753 0 32533 Dorothy Jones 55.0 0.0 X 167176 0 9572 Carol Corcoran 55.0 0.0 X 242753 0 16312 Margo Lucero 55.0 0.0 X 172275 0 31824 Lynn Erdman 55.0 0.0 X 188069 0 20541 Kay Rohlman 55.0 0.0 X 173784 0 30340 Nancy MacGregor 55.0 0.0 X 173960 0 13791 British Robinson 55.0 0.0 X 202593 0 8948 Larry Lundy 55.0 0.0 X 165516 0 16304 Samuel Cheng 55.0 0.0 X 158506 0 14955 Nora Davis 55.0 0.0 X 156892 0 16130 4126534 0 366478 47 false true false Event 360 Inc 205 N Michigan Avenue Chicago IL 606015927 Event Management 9815072 Convio Inc POBox 671445 Dallas TX 752671445 Donation Processing 2204968 Merkle Response Services Inc PO Box 64897 Baltimore MD 21264 Donation Processing 2114126 Radarworks 6100 Wilshire Blvd Los Angeles CA 90048 Marketing 1565798 Adecco Employment Services 175 Broadhollow Road MELVILLE NY 11747 Temp Staffing Svcs 986107 39 1398689 0 53942160 0 0 63316103 101886 118656952 Affiliate Payments 900099 26281480 26281480 0 0 26281480 4443483 4443483 0 367325 367325 0 0 0 27496010 24571153 2924857 2924857 2924857 3622575 53942160 10600543 -6977968 -6977968 0 557685 783219 -225534 -225534 Support services 900099 500000 500000 0 0 Other 900099 351342 0 0 351342 851342 146321937 26555946 0 1109039 X 45152375 45152375 0 4730543 4730543 0 0 3429061 2743248 205744 480069 0 0 0 0 18562559 13442649 3678669 1441241 651414 468719 129386 53309 2039813 1453187 417840 168786 1258471 912176 243697 102598 0 0 0 0 412333 277888 114822 19623 684267 492528 115568 76171 4053 4053 0 0 1598294 1598294 282650 226120 16959 39571 0 0 0 0 25377706 19882579 605439 4889688 9457437 5280930 111319 4065188 3119367 2494228 188839 436300 0 0 0 0 1952448 1450503 339306 162639 2705682 2157127 298304 250251 0 0 0 0 1652775 1028228 57632 566915 0 0 0 0 0 0 0 0 1379701 1035451 195295 148955 213634 178144 18859 16631 CONSULTING & PROF SERVICES 18131846 15016579 845184 2270083 EQUIP RENTAL & MAINTENANCE 1124831 408827 315504 400500 EVENT PRODUCTION 5586156 4638852 252340 694964 BANK FEES 2682871 733604 79254 1870013 7672909 6832741 473850 366318 159863196 131041279 8703810 20118107 X 52772485 31857781 1619964 19294740 X 0 0 56524309 28421714 45091699 41066118 1158074 729495 0 0 0 0 4281900 4170597 508986 399594 2016583 1812789 12491627 10975607 2632862 1516020 200889907 205933377 0 10539546 0 0 0 0 0 0 313104320 294589250 24795633 17873404 166183341 156557964 2022272 1481552 0 0 0 0 0 0 0 0 0 0 0 0 193001246 175912920 X 78174629 81533610 41603445 36817720 325000 325000 120103074 118676330 313104320 294589250 X -13541259 8802998 -341038 3652555 X false true X true false X 127995868 134999587 174658160 159779664 118656952 716090231 0 0 0 0 0 0 0 0 0 0 0 0 127995868 134999587 174658160 159779664 118656952 716090231 422210 715668021 6957976 3548746 3812083 4528150 4810808 23657763 0 0 0 0 0 0 71369 2589864 84038 378313 351342 3474926 743222920 186603111 0.96293 0.95731 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 83839 4053 60995 4053 144834 151155333 302332256 151159386 302477090 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 295135 552301 656218 144834 1648488 250000 250000 250000 250000 1000000 1500000 219954 439745 519831 83839 1263369 Lobbying Expenses Schedule C Part II-A Public policy initiatives have the potential to impact people touched by BREAST CANCER. RECOGNIZING THE POWER OF ADVOCACY TO ACCOMPLISH ITS MISSION, KOMEN SUPPORTS LIMITED LOBBYING ACTIVITIES TO ACHIEVE EVIDENCE-BASED POLICY AND LEGISLATIVE SOLUTIONS DESIGNED TO ELIMINATE BREAST CANCER AS A MAJOR HEALTH PROBLEM. 1325000 0 21 0 21 1325000 1225000 100000 33 0 33 1325000 1225000 608 0 608 1225000 1225000 4284 -4284 0 0 1225000 1318022 5240 98262 0 1225000 0.75000 0.25000 0.00000 false false 795974 644387 151587 4133812 3906709 227103 7561841 6424511 1137330 1516020 0 0 X Schedule D, Part V, Line 4 Intended use of endowment funds There are three permanent endowments: Goodman-Brinker, Firnberg and a General Endowment. Goodman-Brinker Endowment to be used for Breast Cancer Research fellowships. Firnberg Endowment to be used for breast cancer educational programs and research awards. The General Endowment's earnings are restricted for organizational mission activities. FIN 48 (ASC740) Financial Statement Disclosure Schedule D, Part X, Line 2 The Organization is subject to a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. There were no uncertain tax positions recorded in the consolidated financial statements at March 31, 2013 or March 31, 2012. true Central America and the Caribbean 0 0 Grantmaking Education 230138 East Asia and the Pacific 0 0 Grantmaking Research 376299 Europe (Including Iceland and Greenland) 0 0 Grantmaking Education 393765 Europe (Including Iceland and Greenland) 0 0 Grantmaking Research 1622263 Middle East and North Africa 0 0 Grantmaking Education 173700 Middle East and North Africa 0 0 Grantmaking Research 219000 North America 0 0 Grantmaking Education 126186 North America 0 0 Grantmaking Research 1375428 South America 0 0 Grantmaking Education 133764 Sub-Saharan Africa 0 0 Grantmaking Education 80000 Central America and the Caribbean 0 5 Program Services Educ & Event Support 56130 Europe (Including Iceland and Greenland) 0 5 Program Services Educ & Event Support 10741 Middle East and North Africa 0 10 Program Services Educ & Event Support 483370 North America 0 10 Program Services Educ & Event Support 189084 Russia and the Newly Independent States 0 1 Program Services Educ & Event Support 1234 South America 0 4 Program Services Educ & Event Support 43718 Sub-Saharan Africa 0 1 Program Services Educ & Event Support 2015 0 36 0 36 5516835 5516835 North America Education 20015 wire transf 0 Central America and the Caribbean Education 67500 wire transf 0 Europe (Including Iceland and Greenland) Research 50000 wire transf 0 Middle East and North Africa Education 37050 wire transf 0 Middle East and North Africa Research 200000 wire transf 0 Central America and the Caribbean Education 25000 wire transf 0 Europe (Including Iceland and Greenland) Research 21000 wire transf 0 Europe (Including Iceland and Greenland) Education 9000 wire transf 0 Europe (Including Iceland and Greenland) Education 50000 wire transf 0 Europe (Including Iceland and Greenland) Education 25000 wire transf 0 Europe (Including Iceland and Greenland) Research 281820 wire transf 0 South America Education 7500 wire transf 0 Central America and the Caribbean Education 22000 wire transf 0 Central America and the Caribbean Education 49965 wire transf 0 Middle East and North Africa Education 46650 wire transf 0 North America Education 106171 wire transf 0 South America Education 20000 wire transf 0 South America Education 49996 wire transf 0 South America Education 7500 wire transf 0 South America Education 48768 wire transf 0 Europe (Including Iceland and Greenland) Research 958242 wire transf 0 Europe (Including Iceland and Greenland) Education 30000 wire transf 0 North America Research 148778 wire transf 0 Europe (Including Iceland and Greenland) Research 175000 wire transf 0 Middle East and North Africa Education 50000 wire transf 0 Europe (Including Iceland and Greenland) Research 30000 wire transf 0 Europe (Including Iceland and Greenland) Education 75000 wire transf 0 Central America and the Caribbean Education 51169 wire transf 0 North America Research 799579 wire transf 0 Middle East and North Africa Education 10000 wire transf 0 East Asia and the Pacific Research 198098 wire transf 0 Europe (Including Iceland and Greenland) Research 71200 wire transf 0 Sub-Saharan Africa Education 80000 wire transf 0 North America Research 226500 wire transf 0 Central America and the Caribbean Education 14504 wire transf 0 Europe (Including Iceland and Greenland) Research 35000 wire transf 0 Europe (Including Iceland and Greenland) Education 34135 wire transf 0 North America Research 40331 wire transf 0 East Asia and the Pacific Research 178201 wire transf 0 North America Research 160240 wire transf 0 Middle East and North Africa Research 19000 wire transf 0 Europe (Including Iceland and Greenland) Education 170630 wire transf 0 Middle East and North Africa Education 25000 wire transf 43 0 false false false false false false Procedures for monitoring Grant Funds outside of the United States Schedule F, Part IV All research, education, screening, and treatment grantees are required to submit, at a minimum, annual financial and progress reports and change requests to their projects. All progress reports and requests are reviewed by qualified staff. See Schedule I, Part IV for more details. X X X X X true Merkle Inc PO Box 64897 Baltimore MD 21264 Direct Marketing false 15827944 1391157 14436787 McKenna Associates 2000 Clarendon Boulevard Arlington VA 22201 Fundraising false 0 207137 0 15827944 1598294 14436787 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY Gbl Race fr cur 3371339 2411797 959542 8417 78797 87016 65737 Brst Cancr 3dy 51358064 49027676 2330388 1384 1987897 1736260 6225307 2 2835332 2502687 332645 5203 116322 288203 57564735 53942160 3622575 15004 2183016 2111479 6291044 10600543 -6977968 Schedule G, Part II Net Income Summary Gross receipts are reduced by the amount of contributions, per IRS instructions. The contributions for Fiscal Year 2013 were $53.9 million. true Adventist Healthcare Inc 1801 Research Blvd Rockville MD 20850 521532556 501c3 229250 0 Screening Albert Einstein College of Med Yeshiva U 1300 Morris Park Ave Bronx NY 104611975 131624225 501c3 413999 0 Research Alexandria Neighborhood Health Services 2 East Glebe Road Alexandria VA 22305 541849891 501c3 25000 0 Education American Association for Cancer Research 615 Chestnut St Philadelphia PA 19106 236251649 501c3 790000 0 Research American Association on HealthDisabilities 110 N Washington St Rockville MD 20854 521884887 501c3 299998 0 Research American Jewish Joint 711 Third Avenue New York NY 100174014 131656634 501c3 231885 0 Education American Society of Clinical Oncology 2318 Mill Road Alexandria VA 22314 136180880 501c3 600000 0 Research Arab Community Center for Economic 6450 Maple Street Dearborn MI 48126 237444497 501c3 50000 0 Education Arlington Free Clinic 2921 11th Street South Arlington VA 22204 541671883 501c3 50000 0 Education Baylor College Medicine One Baylor Plaza Houston TX 770303411 741613878 501c3 1938700 0 Research Beckman Research Inst City of Hope 1500 East Duarte Rd Duarte CA 910103000 953432210 501c3 40000 0 Research Beth Israel Deaconess Medical Center 330 Brookline Avenue Boston MA 02215 042103881 501c3 530000 0 Research Boat People SOS 6066 Leesburg Pike Falls Church VA 22041 541563619 501c3 450000 0 Education, Screening, Treatment Boise State University 1910 University Dr Boise ID 837251247 820290701 501c3 160000 0 Research Boston University School of Medicine 580 Harrison Avenue 3-W Boston MA 02118 042103547 501c3 391000 0 Research Boston VA Research Institute 150 S Huntington Ave Boston MA 02130 043081524 501c3 15952 0 Research Brigham and Women's Hospital PO Box 3149 Boston MA 022413149 042312909 501c3 521005 0 Research Burnham Institute for Medical Research 10901 N Torrey Pines Rd La Jolla CA 92037 510197108 501c3 150000 0 Research California Pacific Medical Center 475 Brannan St San Francisco CA 94107 940562680 501c3 137988 0 Research Cancer Care 275 Seventh Avenue New York NY 10001 131825919 501c3 500000 0 Treatment Cancer Support Community 1050 17th Street NW Washington DC 20036 954163931 501c3 20000 0 Education Capital Breast Care Center 650 Pennsylvania Ave Washington DC 20003 530196603 501c3 50000 0 Education Capitol City Area Health Education Cente 1700 E Capitol St Washington DC 20003 263301051 501c3 300000 0 Education, Screening, Treatment CASA of Maryland Inc 8151 15th Avenue Hyattsville MD 20783 521372972 501c3 50000 0 Education Case Western Reserve University 10900 Euclid Av Cleveland OH 44106 341018992 501c3 139993 0 Research C-Change 1776 I Street Washington DC 20006 161641769 501c3 225000 0 Education Cedars Sinai Medical Center 8700 Beverly Blvd Los Angeles CA 90048 951644600 501c3 29733 0 Research Center for Infectious Disease Research 5335 Wisconsin Ave NW Washington DC 20015 980514692 501c3 20300 0 Education Children's Hospital Boston PO Box 414413 Boston MA 022414413 042774441 501c3 96000 0 Research Children's Memorial Hospital 225 E Chicago Box 205 Chicago IL 60611 362170833 501c3 12000 0 Research Clemson University 113 Riggs Hall Clemson SC 296340901 576000254 501c3 11999 0 Research Cleveland Clinic Foundation 9500 Euclid Avenue P84 Cleveland OH 44195 340714585 501c3 48000 0 Research Cold Spring Harbor Laboratory 1 Bungtown Rd Cold Spring Harbor NY 11724 112013303 501c3 132000 0 Research Columbia University Medical Center 615 West 131st St New York NY 10027 135598093 501c3 409727 0 Research Commonwealth PO Box 316 Bolinas CA 94924 942366094 501c3 22717 0 Education Cornell University 341 Pine Tree Road Ithaca NY 14850 150532082 501c3 1172352 0 Research Dana-Farber Cancer Institute 44 Binney Street BP431C Boston MA 02115 042263040 501c3 858817 0 Research Dartmouth College 63 South Main Street Hanover NH 03755 020222111 501c3 150000 0 Research District of Columbia Cancer Consortium 5225 Wisconsin Ave NW Washington DC 20015 521653537 501c3 37500 0 Education Doctors Community Hospital 8116 Good Luck Rd Lanham MD 207063502 521638026 501c3 750000 0 Education, Screening, Treatment Duke University Medical Center 2200 West Main St Durham NC 27705 560532129 501c3 1161603 0 Research Eastern Michigan University 324 Blackwell St Ypsilanti MI 48197 386005986 501c3 134552 0 Education EO Lawrence Berkeley National Laboratory 204 Hover Building Berkeley CA 94701 942951741 501c3 15087 0 Research Facing Our Risk of Cancer Empowered 16057 Tampa Palms Blvd Tampa FL 33647 650927702 501c3 100000 0 Education Foundation of the NIH 9650 Rockville Pike Bethesda MD 20814 521986675 501c3 40000 0 Research Fox Chase Cancer Center 333 Cottman Ave Philadelphia PA 19111 232003072 501c3 272218 0 Research Fred Hutchinson Cancer Research Center PO Box 19024 Seattle WA 981091024 563744111 501c3 465000 0 Education, Research Fred Hutchinson Cancer Resrch 1100 Fairview Ave Seattle WA 981091024 237156071 501c3 199907 0 Research Friends of Cancer Research 2231 Crystal Drive Arlington VA 22202 521983273 501c3 40000 0 Education George Mason University 4400 University Dr Fairfax VA 22030 541603842 501c3 222310 0 Research George Washington University 2300 Eye Street Washington DC 200520011 530196584 501c3 750000 0 Education, Screening, Treatment Georgetown University LCC LL Level Room S155 Washington DC 20007 530196603 501c3 581671 0 Research Greater Baden Medical Services Inc 7450 Albert Rd Brandywine MD 20316 520961414 501c3 399800 0 Screening, Treatment Harvard Medical School 25 Shattuck Street Boston MA 02115 042103580 501c3 452182 0 Research Henry Ford Health System One Ford Place 5E Detroit MI 48202 381357020 501c3 198037 0 Research Holy Cross Hospital 1500 Forest Glen Rd Silver Spring MD 20910 597910280 501c3 250000 0 Education Howard University Cancer Center 2041 Georgia Ave Washington DC 200600001 530204707 501c3 536472 0 Education, Screening, Treatment I Am Too Young For This Cancer Fdn 40 Worth Street 808 New York NY 10013 202027782 501c3 30000 0 Education Indiana University School of Medicine PO Box 66057 Indianapolis IN 462666057 356001673 501c3 1203299 0 Research International Breast Cancer 660 John Nolan Drive Madison WI 53711 391766858 501c3 117115 0 Research International Scholarship & Tuition Serv 1321 Murfreesboro Road Nashville TN 37217 621247492 501c3 65000 0 Education Johns Hopkins University 1101 East 33rd St Baltimore MD 21218 525951100 501c3 919281 0 Research Karmanos Cancer Institute 4100 John R VE01FS Detroit MI 48201 381613280 501c3 166241 0 Research Korean Community Svc Ctr of Greater WA 7700 Lt River Turnpike Annandale VA 22003 521128174 501c3 45000 0 Education Lankenau Institute for Medical Research 100 Lancaster Avenue Wynnewood PA 19096 232175659 501c3 199628 0 Research Lawrence Berkeley National Laboratory PO Box 528 Berkeley CA 94701 942951741 501c3 11947 0 Research Leland Stanford Jr University 3145 Porter Drive Palo Alto CA 94304 941156365 501c3 503536 0 Research Living Beyond Breast Cancer 354 W Lancaster Ave Haverford PA 19041 232734689 501c3 175000 0 Education Loyola University 820 N Michigan Ave Chicago IL 60611 361408475 501c3 39888 0 Research Maasai Wildernes Conservation Fund PO Box 1413 Santa Barbara CA 93102 660627488 501c3 50000 0 Education Mary's Ctr for Maternal&Child Care Inc 2333 Ontario Road NW Washington DC 20009 521594116 501c3 50000 0 Education Massachusetts General Hospital 101 Huntington Ave Boston MA 02199 042697983 501c3 453601 0 Research Mayo Clinic and Foundation 4500 San Pablo Rd Jacksonville FL 32224 416011702 501c3 659850 0 Research Mayo Clinic Rochester 200 First St Rochester MN 55905 416011702 501c3 114044 0 Research Memorial Sloan-Kettering Cancer Ctr 633 3rd Ave New York NY 10017 131924236 501c3 589108 0 Research Mercy Medical Ctr 301 St Paul Place Baltimore MD 21202 521495113 501c3 349875 0 Research Methodist Hospital Research Institute PO Box 4805 Houston TX 772104805 870721923 501c3 118863 0 Research Metropolitan Chicago Breast Cancer 1645 W Jackson Blvd Chicago IL 60612 262264895 501c3 633333 0 Screening Mount Sinai School of Medicine 633 Third Avenue New York NY 10017 136171197 501c3 409991 0 Research Muslim Community Center Medical Clinic 15200 Newhampshire Silver Spring MD 20905 521072792 501c3 24990 0 Screening National Academy of Sciences 730 15th Street NW Washington DC 20005 530196932 501c3 111901 0 Research National Cancer Institute 6130 Executive Blvd Rockville MD 20852 521986675 501c3 225000 0 Education New York University School of Medicine One Park Ave New York NY 10016 135562308 501c3 308000 0 Research Northwestern Univ - Evanston 633 Clark St Evanston IL 60208 362167817 501c3 35563 0 Research Northwestern University 633 Clark Street Evanston IL 60208 362167817 501c3 413902 0 Research Nueva Vida Inc 2000 P Street NW Washington DC 20036 541943145 501c3 50000 0 Education Oncology Nursing Society 125 Enterprise Dr Pittsburgh PA 15275 251410081 501c3 35000 0 Research Oregon Health & Science University 0690 SW Bancroft St Portland OR 97239 237083114 501c3 1975590 0 Screening, Research Patient Advocate Foundation 421 Butler Farm Road Hampton VA 23666 541806317 501c3 1375000 0 Education, Treatment Penfold-Patterson Research Institute 1700 El Camino Real Menlo Park CA 94025 270578063 501c3 50000 0 Research Pennsylvania State Univ Coll of Medicine MCG230 PO Box 850 Hershey PA 17033 246000376 501c3 892256 0 Research Prevent Cancer Foundation 1600 Duke Street Alexandria VA 22209 521429544 501c3 49975 0 Education Primary Care Coalition-MontgomeryCty Inc 8757 Georgia Ave Silver Spring MD 20910 521847976 501c3 588264 0 Screening, Treatment Prince George's County Health Dept 1701 McCormick Drive Largo MD 20774 522046026 501c3 153076 0 Education Princeton University 701 Carnegie Center Princeton NJ 08540 216345010 501c3 256250 0 Research Program for Appropriate PO Box 900922 Seattle WA 98109 911157127 501c3 100000 0 Education Project Concern International 121 E 31st Street National City CA 91950 952248462 501c3 25000 0 Education Proteogenomics Research Institute 11107 Roselle Street San Diego CA 92121 800418281 501c3 160000 0 Research Providence Health Foundation 1150 Varnum Street NE Washington DC 20017 521275583 501c3 125000 0 Screening Providence Portland Medical Center 4805 NE Glisan St Portland OR 97213 930386906 501c3 311963 0 Research Research Advocacy Network 6505 West Park Boulevard Plano TX 75093 352209499 501c3 59608 0 Research Research Foundation of SUNY 35 State Street Albany NY 12207 141368361 501c3 11963 0 Research Riverside Research Institute 156 William St New York NY 10038 132593244 501c3 39741 0 Research Roswell Park Alliance Foundation Elm Carlton Streets Buffalo NY 14263 161391608 501c3 232274 0 Research Rush University 1700 West Van Buren Chicago IL 60612 362174823 501c3 150000 0 Research Scripps Research Institute 10550 N Torrey Pines Rd La Jolla CA 92037 330435954 501c3 48000 0 Research Smith Farm Center for Healing & the Arts 1632 U Street NW Washington DC 20009 521977976 501c3 25000 0 Education Society for Surgical Oncology 85 W Algonquin Rd Arlington Hts IL 60005 136161070 501c3 77500 0 Research Southern Illinois University PO Box 19616 Springfield IL 627949616 376005961 501c3 107000 0 Research Stanford University PO Box 44253 San Francisco CA 941444253 941156365 501c3 240000 0 Research SUNY at Stony Brook W5510 Melville Library Stony Brk NY 11794 141368361 501c3 73998 0 Research The ASCO Cancer Foundation 2318 Mill Road Alexandria VA 22314 311667995 501c3 1275000 0 Research The Caring Foundation PO Box 2266 Cheyenne WY 82003 830292601 501c3 433783 0 Screening The Center For Mind - Body Medicine 5225 Connecticut Av Washington DC 20015 521755744 501c3 10000 0 Education The General Hospital Corp 50 Staniford St Boston MA 02114 041564655 501c3 140439 0 Research The Hope Foundation 24 Frank Lloyd Dr Ann Arbor MI 48106 742655302 501c3 85400 0 Research The Mautner Project 1300 19th Street NW Washington DC 20036 521703915 501c3 50000 0 Education The Salk Institute 10010 N Torrey Pines Rd La Jolla CA 92037 956136024 501c3 50000 0 Research The University of Chicago 970 East 58th St Chicago IL 60637 362177139 501c3 575000 0 Research The Wistar Institute 3601 Spruce Street Philadelphia PA 19104 236434390 501c3 191416 0 Research Thomas Jefferson University 1020 Walnut St Philadelphia PA 19107 232829095 501c3 1559998 0 Research Trustees of Columbia Univ 615 West 131st St New York NY 10027 133957095 501c3 29693 0 Research Tufts University 136 Harrison Avenue Boston MA 02111 043532914 501c3 170366 0 Research UMDNJ Robert Wood Johnson MC 335 George St New Brunswick NJ 08901 237313160 501c3 44978 0 Research Univ of Arkansas for Medical Sci 4301 W Markham Little Rock AR 722057199 716056774 501c3 49972 0 Education Univ of Colo Denver Health Sciences Ctr PO Box 910238 Denver CO 802910238 856000555 501c3 180000 0 Research Univ of Colorado Health Sciences Center Fitzsimons Bldg Denver CO 80291 846000555 501c3 309323 0 Research Univ of Kentucky Research FDN 201 Kinkead Hall Lexington KY 405060005 616033693 501c3 32361 0 Research Univ of North Carolina at Chapel Hill 104 Airport Dr Chapel Hill NC 27599 566001393 501c3 824617 0 Research Univ of North Carolina at Charlotte 9201 University Blvd Charlotte NC 28223 566001393 501c3 48000 0 Research Univ of Texas MD Anderson Cancer Center PO Box 4390 Houston TX 772104390 746001118 501c3 382831 0 Research Univ of TX MD Anderson Cancer Center 1515 Holcombe Blvd Houston TX 77030 746001118 501c3 179999 0 Research University Miami School of Medicine 1400 NW 10th Avenue Miami FL 33136 590624458 501c3 438179 0 Research University of Alabama at Birmingham 1720 2nd Avenue South Birmingham AL 35294 636005396 501c3 200000 0 Research University of Arizona PO Box 3520 Tucson AZ 85722 742652689 501c3 40225 0 Research University of CA at San Diego 9500 Gilman Dr La Jolla CA 92093 956006144 501c3 529845 0 Research University of California at San Francisco 3333 California St San Francisco CA 94118 946036493 501c3 1070159 0 Research University of California at Santa Cruz 1156 High Street Santa Cruz CA 95064 941539563 501c3 60000 0 Research University of California-Berkeley 2195 Hearst Avenue Berkeley CA 94720 946090626 501c3 60000 0 Research University of California-Davis 1 Shields Ave Davis CA 95616 946036494 501c3 223485 0 Research University of California-Irvine Biological Science 3 Irvine CA 92697 952226406 501c3 248000 0 Research University of California-Los Angeles 10920 Wilshire Blvd Los Angeles CA 90024 956006143 501c3 440000 0 Research University of Central Florida 12424 Research Pkwy Orlando FL 32828 593086453 501c3 171994 0 Research University of Cincinnati 51 Goodman Dr Cincinnati OH 452210222 316000989 501c3 40000 0 Research University of Florida 219 Grinter Hall Gainesville FL 32611 596002052 501c3 39974 0 Research University of Hawaii 2530 Dole St Honolulu HI 96822 996000354 501c3 11441 0 Research University of Houston 4800 Calhoun Rd Houston TX 77204 746001399 501c3 95660 0 Education University of Illinois 1901 S First St Champaign IL 618207406 376006007 501c3 38549 0 Research University of Illinois at Chicago 809 S Marshfield Ave Chicago IL 60608 376000511 501c3 351007 0 Research University of Iowa at Carver College of B5 Jessup Hall Iowa City IA 52242 426004813 501c3 12000 0 Research University of Kansas Medical Center 3901 Rainbow Blvd Kansas City KS 66160 481108830 501c3 187965 0 Research University of Louisville 521 Stevenson Hall Louisville KY 40292 611029626 501c3 74134 0 Research University of Maryland 660 W Redwood St Baltimore MD 21201 522238893 501c3 70000 0 Research University of Maryland-Baltimore PO Box 41428 Baltimore MD 202036428 311678679 501c3 208000 0 Research University of Michigan 3086 Wolverine Tower Ann Arbor MI 48109 386006309 501c3 400000 0 Research University of Minnesota 200 Oak Street SE Minneapolis MN 55455 416007513 501c3 693428 0 Research University of Mississippi Medical Center 2500 North State Street Jackson MS 39216 646008520 501c3 94213 0 Research University of Nebraska 985100 Nebraska Medical Ctr Omaha NE 68198 047049123 501c3 60000 0 Research University of Nebraska Medical Center 985100 Nebraska Med Ctr Omaha NE 68198 063682242 501c3 52000 0 Research University of North Carolina 104 Airport Drive Chapel Hill NC 27599 566001393 501c3 31409 0 Research University of Oklahoma Health Sciences 1100 N Lindsay Oklahoma City OK 73104 736017987 501c3 231705 0 Research University of Pennsylvania 3451 Walnut St Philadelphia PA 191046205 231352685 501c3 732481 0 Research University of Pittsburgh PO Box 371220 Pittsburgh PA 152517220 250966691 501c3 69503 0 Research University of South Dakota 2301 East 60th St N Sioux Falls SD 57104 466003541 501c3 160122 0 Research University of Tennessee UT GSM 1924 Alcoa Hwy Knoxville TN 37920 311626179 501c3 147616 0 Research University of Texas at Health Science ctr PO Box 20036 Houston TX 77030 741587488 501c3 210825 0 Research University of Texas Health Science Ctr 7703 Floyd Curl Dr San Antonio TX 78229 741586031 501c3 200000 0 Research University of Utah 201 S Presidents Salt Lake City UT 84112 876000525 501c3 197999 0 Research University of Vermont 85 S Prospect St Burlington VT 05405 031794400 501c3 21766 0 Research University of Virginia PO Box 400195 Charlottesville VA 22904 541682176 501c3 455436 0 Research University of Washington 3917 University Way NE Seattle WA 98105 916001537 501c3 230000 0 Research University of Washington at Seattle 1100 NE 45 St Suite 300 Seattle WA 98105 916001537 501c3 40000 0 Research University of Wisconsin - Madison 21 North Park St Madison WI 53715 396006492 501c3 363847 0 Research UNT Health Science Center Att LeAnn Forsberg Fort Worth TX 76107 756064033 501c3 48000 0 Research USCD School of Medicine 9500 Gilman Dr La Jolla CA 92093 956006144 501c3 12000 0 Research UT Health Center at Tyler 11937 US Highway 271 Tyler TX 75708 756001354 501c3 132923 0 Research UT Health Science Center at San Antonio 7703 Floyd Curl Drive San Antonio TX 78229 741586031 501c3 298000 0 Research UT Southwestern Medical Center at Dallas 5323 Harry Hines Blvd Dallas TX 75390 756002868 501c3 98000 0 Research, Education UTMD Anderson Cancer Ctr 1515 Holcombe Blvd Houston TX 77030 746001118 501c3 532710 0 Research Vanderbilt University Medical Center 2200 Pierce Avenue Nashville TN 37232 620476822 501c3 800562 0 Research Vietnamese Resettlement Association Inc 7297 Lee Highway Falls Church VA 22042 541512549 501c3 50000 0 Education Virginia Commonwealth University PO Box 843039 Richmond VA 232843038 546001758 501c3 344815 0 Research Wake Forest University Health Sciences Medical Ctr Blvd WinstonSalem NC 27157 223849199 501c3 210973 0 Research Washington Cancer Institute 110 Irving St NW Washington DC 20010 521791670 501c3 50000 0 Education Washington University in St Louis 700 Rosedale Ave Saint Louis MO 63112 430653611 501c3 2478026 0 Research Wayne State University 5057 Woodward Ave Detroit MI 48202 383555142 501c3 539979 0 Research Weill Medical College of Cornell Univ 575 Lexington Av New York NY 10022 150532082 501c3 12000 0 Research West Virginia University 886 Chestnut Ridge Rd Morgantown WV 26506 550665758 501c3 270000 0 Research Whitehead Inst for Biomedical Research 9 Cambridge Ctr Cambridge MA 02142 061043412 501c3 224000 0 Research Widener University One University Place Chester PA 19013 231386178 501c3 231771 0 Research Wyoming Foundation for Cancer CareLLC 6501 E 2nd Street Casper WY 82609 204190331 501c3 166217 0 Screening Yale University School of Medicine 47 College St Ste 216 New Haven CT 06510 060646973 501c3 217750 0 Research YWCA of San Antonio 314 N Hackberry San Antonio TX 78202 741143135 501c3 49715 0 Education 179 Form 990, Schedule I Procedures for Monitoring the Use of Grants Susan G. Komens (Komen) policies for managing research grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the review and funding process. Throughout the term of the grant, scientific progress is monitored by a Ph.D.-level Science Manager. Grantee is required to submit scientific progress reports on each anniversary of the grant start date for the duration of the project, except for the final year of the grant when a final report is due no later than 30 days after the end date of the grant term. A scientific progress report also is due if the Grantee is requesting an extension to the end of the grant term or acceleration of the Grant term. With reasonable prior notice to Grantee, Komen may require additional reporting from Grantee and also may require Grantee to participate in site visits, telephone conferences, presentations or other speaking engagements. All Grant funds must be expended in accordance with the project's approved budget. Komen will disburse the first year's budgeted Grant funds within thirty (30) days of the effective date of the Grant. For each additional year, excluding the final year of the Grant term, Komen will disburse one hundred percent (100%) of the budgeted funds for that year after review and approval of a satisfactory and timely scientific progress report and financial report for the prior year and any other documents requested by Komen for its approval. For the final year of the Grant, Komen will disburse eighty percent (80%) of the approved budget funds after review and approval of a satisfactory scientific progress report and financial report for the prior year and any other documents requested by Komen for approval. The remaining twenty percent (20%) of funds will be disbursed upon receipt of a satisfactory final research report, final financial report, and any other documents required by Komen. As part of its oversight of research progress, Komen may adjust the project reporting period and associated disbursement of Grant funds at any time during the Grant term with prior written notice to Grantee. Annual financial reports are due no later than 30 days after each anniversary of the Grant start date for the duration of the grant term, with the exception of the final financial report, which is due no later than 60 days after the end date of the Grant term. All expenditures must be reported in United States dollars ($USD). Grantee must submit a Request for a Budget Change in the event grantee wishes to move funds across budget categories in excess of the allowable limits. The unexpended funds must be remitted with the final financial report to Komen, unless otherwise specified. Komen will not be responsible for a) any expenditure made prior to the effective date or after the termination of the Grant, b) commitments made during the Grant term but not paid within sixty (60) days following the expiration of the Grant Agreement, c) expenditures that are not permitted as described within the RFA, or d) any expenditure that is inconsistent with the approved Research Plan and budget or that exceeds the total amount of the Grant. Komen or its designated representatives shall have the right to request and receive from a Grantee, or any of its subcontractors, copies of any and all documents and other information related to the Grant at any time during or after the term of the Grant. This right includes, but is not limited to, the right to review all financial books and records related to the Grant and to perform an audit of all expenses related directly or indirectly to the Grant. Komen's policies for managing community grants and other non-research related grants from the time of initial award through completion seek to maximize flexibility while maintaining the highest standard of accountability and preserving the integrity of the funding process. All grantees must sign a grant contract which sets forth the terms of the grant, including the purpose of the grant, amount, budgetary restrictions, duration, payment schedule, reporting requirements, and audit and early termination rights for Komen. The grantee is required to submit progress reports (typically every six months) that detail progress towards meeting each of the objectives and any challenges encountered. The report must also include a full accounting of grant funds expended (actual versus budgeted expenses). The Program Manager may conduct site visits with the grantees, when appropriate, to build a stronger relationship with the grantee; to gain a better understanding of its work; and to address any challenges or problems the grantee is facing. Any changes to the project must be approved by Komen's Program Manager in writing in advance of the change. A final report must be provided at the completion or early termination of the grant and must include, among other things, a financial report and an evaluation of the programs accomplishments and impact in the community. Any unexpended funds must be remitted with the final report to Komen unless otherwise directed. X true true X X X X X true false false false false false false false false Lesley Lurie 178972 0 0 0 2233 0 10267 0 16384 0 207856 0 0 0 Elizabeth Thompson 336839 0 0 0 269622 0 10560 0 15492 0 632513 0 0 0 David Dawson 206296 0 0 0 2379 0 9347 0 20638 0 238660 0 0 0 Chandini Portteus 195788 0 0 0 1965 0 11993 0 20540 0 230286 0 0 0 Dorothy Jones 165684 0 0 0 1492 0 0 0 9572 0 176748 0 0 0 Carol Corcoran 237396 0 0 0 5357 0 5387 0 10925 0 259065 0 0 0 Nancy MacGregor 89431 0 0 0 84529 0 5512 0 8279 0 187751 0 0 0 Margo Lucero 170381 0 0 0 1894 0 10630 0 21194 0 204099 0 0 0 British Robinson 197684 0 0 0 4909 0 0 0 8948 0 211541 0 0 0 Lynn Erdman 184151 0 0 0 3918 0 0 0 20541 0 208610 0 0 0 Larry Lundy 141494 0 0 0 24022 0 8497 0 7807 0 181820 0 0 0 Samuel Cheng 134759 0 0 0 23747 0 8134 0 6821 0 173461 0 0 0 Nora Davis 155572 0 0 0 1320 0 7308 0 8822 0 173022 0 0 0 Kay Rohlman 170384 0 0 0 3400 0 10563 0 19777 0 204124 0 0 0 Mark Nadolny 302952 0 0 0 4712 0 13543 0 17921 0 339128 0 0 0 Nancy G Brinker 549380 0 0 0 11516 0 14978 0 8761 0 584635 0 0 0 Form 990, Schedule J, Part I, Line 1a Supplemental Compensation Information First class and business class fares for domestic travel, Canada, the Caribbean, Central America, and Mexico are not reimbursable. However, personal frequent flier mileage and/or coupons may be used for no-cost upgrades. Only the CEO/Founder is approved for first class travel. Business Class was approved for one individual on an occasional basis due to medical necessity surrounding flights of greater than 4 hours. Whenever possible, discounted first class and upgrades are used to minimize cost. Schedule J, Part I, line 4a During calendar year 2012 the following severance payments were made: Elizabeth Thompson - $266,900 Nancy MacGregor - $82,793 Larry Lundy - $21,486 Samuel Cheng - $18,739 X 99578 Cost or sale price X 2 2308 Cost or sale price false true false VOLUNTEERS Form 990, Part I, Question 6 Volunteers serve in a variety of ways but the greatest numbers of volunteers assist with the Susan G. Komen 3 Day series. Program Service Accomplishments Form 990, Part III, Lines Nancy G. Brinker promised her dying sister, Suzy, she would do everything in her power to end breast cancer. Susan G. Komen(Komen) works to end breast cancer in the U.S. and throughout the world by investing in breast cancer research and community outreach programs; providing funding to help low-income and uninsured women get screened and get treatment; advocating for cancer research and outreach programs; and working globally in more than 30 countries. A - Research and Training Komen has contributed to major advances in breast cancer research over the past 30 years. Komen's Research and Training Grant Program is designed to advance the translation of research discoveries into new ways to diagnose, treat, and prevent breast cancer, leading to a reduction of breast cancer incidence and mortality within the next decade. To ensure maximum impact for its research dollars, Komen is guided by a Scientific Advisory Board, a group of internationally recognized doctors, scientists and advocates, and consults with the Komen Scholars, a group comprised of 70 scientists and advocates. Komen awards grants to individual scientists, research teams, and organizations around the world through competitive review processes that ensure maximum impact for our research dollars. In fiscal year 2013, Komen awarded 124 grants through its Research and Training Grants Program to support research and training in the United States and other countries, including Australia, Belgium, Canada, England, France, Italy, Spain, and Switzerland. The following Request-for-Applications-driven grant opportunities were offered by Komen during fiscal year 2013: Challenge Grants: Breast Cancer and the Environment Grants to address key research needs in the field of environmental contributions to breast cancer risk. Komen and its Scientific Advisory Board requested that the Institute of Medicine (IOM) review the current evidence on environmental risk factors for breast cancer, consider gene-environment interactions in breast cancer, explore evidence-based actions that might reduce the risk of breast cancer, and recommend research needed in these areas. At the conclusion of its grant, IOM issued 13 recommendations for further research, of which the following three have been chosen by the Komen Scientific Advisory Board as the subject of Challenge Grants awarded in fiscal year 2013: *Studies of Occupational Cohorts and Other Highly Exposed Populations *New Exposure Assessment Tools *Minimizing Exposure to Ionizing Radiation Investigator Initiated Research: Grants to explore new ideas and approaches with significant potential to lead to reductions in breast cancer mortality and/or incidence within the decade, with a focus on the following: *Prevention/Early Detection: New Strategies for Early Detection *Novel Therapeutics and/or Resistance: Therapeutic Implications of Tumor Genomics *Biology of Breast Cancer: Implications of the Immune System in Breast Cancer Biology *Disparities in Breast Cancer Outcomes: Outcomes of Specific Populations after Diagnosis Career Catalyst Research: Grants to fill a critical gap in support and stimulate the transition from training to independence among promising cancer investigators. Komens research investment through the above grant mechanisms will support projects including, but not limited to, the following goals: *Identify the true drivers of resistance in HER2+ breast cancer, which can subsequently be targeted in combination therapy, thus circumventing resistance. *Identify molecular markers to predict and track response to treatment targeted to ER+ breast cancer, and understand pathways of resistance that can inform and change the treatment regimen. *Seek to develop new molecular markers for progression from in situ to invasive breast cancer. *Use improved digital imaging to better capture breast calcifications and reduce secondary screenings. *Seek to understand how breast cancer escapes the immune system. *Develop a vaccine to treat metastatic breast cancer. *Understand how genes involved in normal breast development are also involved in breast cancer progression. *Develop new treatments for triple negative and other aggressive, treatment-resistant disease. *Identify determinants of survival that are modifiable, to save women from sub-Saharan Africa of death from breast cancer. *Seek to improve outcomes among minority and low-income women through stress and fatigue management. Opportunity Grants / Sponsored Programs and Partnership Grants: Grants to support special research projects, programs, and collaborations that leverage research and community resources to facilitate the development of the infrastructure, tools, and other means to accelerate the translation of scientific discoveries from bench to bedside to curbside. Examples of Opportunity Grants committed in fiscal year 2013 include: *The Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center ("Komen Tissue Bank," "Tissue Bank" or "KTB"), a biorepository of whole blood, DNA, serum, plasma, frozen human breast, formalin-fixed, paraffin-embedded breast tissue, and cell lines derived from the breast tissue, and the first and only biorepository of normal breast tissue in the world. The mission of the Komen Tissue Bank is to facilitate progress in breast cancer research by providing researchers across the globe with richly annotated biospecimens of the highest quality and the experimental data derived from these specimens. The Komen Tissue Bank, a model for biorepositories, represents a major change in research of breast biology and will hopefully have a huge impact in our community and the world. It has the potential to help identify people at risk for breast cancer as well as those not at risk for the development of the disease. *The International Program on Male Breast Cancer (International Registration and Biologic Characterization Program) organized by the European Organization for Research and Treatment of Cancer (EORTC), the Breast International Group (BIG), and the North American Breast Cancer Groups (NABCG, former TBCI) aims to better characterize the clinical features, biology, and outcomes for men diagnosed with breast cancer. Examples of Sponsored Programs and Partnership Grants committed in fiscal year 2013 include: *Support for the Accelerating Anti-Cancer Drug Development Workshop, which is designed for scientists and consumer advocates with clinical trial experience who have an interest in new approaches to developing or enhancing agents or combinations of agents for the diagnosis, treatment or prevention of cancer. This groundbreaking Workshop is designed to bring together leaders in clinical and translational cancer research from academia, industry, NCI and FDA to assist investigators in understanding and improving the process of cancer drug development. The goal is to expedite the development and validation processes for new anticancer and cancer prevention agents so they can be made available to patients at an accelerated rate. *Support for the Friends of Cancer Research 2013 Conference on Clinical Cancer Research, which focuses on addressing critical issues in the development of new oncology drugs. Friends of Cancer Research and the Engelberg Center for Health Care Reform at Brookings will co-host the sixth annual Conference on Clinical Cancer Research. This annual conference brings together leaders in cancer drug development from federal health and regulatory agencies, academic research, and the private sector for focused discussions on key issues surrounding the development and regulation of cancer drugs and therapies. B - Education Komen is a trusted source of breast cancer information for people all over the world and is instrumental in connecting people with the resources they need in their fight against breast cancer. Our award-winning website, www.komen.org, provides safe, accurate, comprehensive, and unbiased information about breast cancer based upon scientific evidence, as well as information about our research programs, community programs, volunteer opportunities, and events. The "Understanding Breast Cancer" section of the website, co-developed with Harvard Medical School faculty and Dana-Farber/Brigham and Women's Cancer Center staff, received over 3.3 million visits during fiscal year 2013. Komen also produces evidence-based, easy-to-read educational materials. Komen and its Affiliates distributed over 5 million educational materials in fiscal year 2013. Examples of Komen educational materials include the following: - Breast Self-Awareness cards in 21 languages and for 22 specific audiences - Breast cancer awareness and breast cancer specific brochures and fact sheets - Booklets with support information for survivors and co-survivors Komen's trained and caring breast care helpline staff (1-877 GO KOMEN, 1-877-465-6636) provide answers to questions, local resources, and moral support. Last fiscal year, the Komen breast cancer helpline responded to over 1,213,000 calls and 1,000,100 emails. While older African American women are less likely to be diagnosed with breast cancer than Caucasian women, they are more likely to die from the disease at every age. Komen's Circle of Promise program engages African American women, and black women around the world, in the fight against breast cancer. As of the end of fiscal year 2013, a total of 100,000 ambassadors had been recruited to do the following: - Mobilize the community to ensure that women everywhere have access to the care they need; - Empower women to make a promise to reclaim their lives, their health, and to be strong advocates in their communities, and - Dispel myths in these communities that prevent women from getting treatment for breast cancer. I AM THE CURE is an educational program that teaches simple, action-oriented, breast cancer information to participants in the Komen Race for the Cure series. Last year, nearly 1.5 million people participated in a Race for the Cure event. A formal evaluation showed that 82% of participants recalled the message that early detection is the key to survival. Cancer kills more people, worldwide, than TB, HIV/AIDS and malaria combined. Komen is waging the global fight against breast cancer by building and strengthening grassroots programs through networking, training, capacity building and financial support. In fiscal year 2013, 168 breast cancer advocates in three countries (Brazil, Costa Rica, and Mexico) were trained on the Community Educators program and Course for the Cure curricula. The Community Educators program is a theory-based trainer curriculum targeted for education program planners and Course for the Cure is a series of capacity building modules based on Komen's best practices and experience aimed at helping local non-government organizations increase their reach and impact. In Partnership with the Caterpillar Foundation, Komen funded programs in Brazil, Panama, and Mexico that reached an estimated 3.3 million people through awareness campaigns and trained 1,681 community health workers and medical providers, while also reaching 24,616 community members through breast self awareness and breast cancer through the end of fiscal year 2013. Also, since inception of the program, these grants provided for the distribution of 232,447 educational materials, 2,678 clinical breast exams, 5,419 mammogram referrals, and 427 mammograms. Komen also awarded grants for outreach programs in Bosnia and Herzegovina, Colombia, Germany, Hungary, Kenya, Mexico, Peru, Russia, Rwanda, The Bahamas, The United Arab Emirates, and Zambia. Furthermore, Komen awarded grants aimed at 1) conducting a comparative baseline needs assessment for breast cancer awareness and management in select countries in the Middle East and North Africa and 2) developing a Global Project Database on women's cancers and conducting a full scale effort to develop a Global Pink Paper/Report, a complimentary body of work focused specifically on women's cancers. C - Screening Getting regular screening tests, along with treatment if diagnosed, lowers the risk of dying from breast cancer. Screening tests can find breast cancer early, when survival is highest. Komen supports free and low-cost mammogram programs in communities for women without health insurance or those with high co-pays and deductibles that make getting a mammogram too costly. In 2013, Komen awarded $1.5 million for seven new community grants to reach low-income, minority and uninsured women who fall through the healthcare gaps in the Washington, D.C. Metro area, where death rates from breast cancer continue to rank above national averages. The new Komen grants bring to 18 the number of Komen-funded programs in the D.C. area that strive to improve access and services to women facing breast cancer, representing a total in active grant funding of $7.3 million. All seven new grants in the Washington, D.C. Metro area focus on addressing barriers to care caused by the region's fragmented heath care system and lack of care coordination among vulnerable patients. All new grantees were required to form partnerships among providers in the region that establish a framework to ensure that patients can be easily and efficiently referred and "navigated" from screening all the way through to survivorship-with particular emphasis on removing obstacles to transportation and work obligations, wait times, and financial assistance. In addition, several of the programs focus on patient education, including targeted breast health awareness outreach in a culturally sensitive manner that develops a better understanding of the importance of screening, the effectiveness of modern treatments and survivorship. Through Komen's National Vulnerable Populations Grants Program, Komen funds large-scale community grants that seek to improve quality of care, care coordination, and address unique barriers to breast care for disparate populations. Since the initiation of these grants in 2008, Komen has invested over $9 million in programs that aim to eliminate disparities in breast cancer mortality. Projects funded in fiscal year 2013 through Komen's National Vulnerable Population Grants Program are focused on quality and systems improvement. Grantees will develop more effective and efficient processes for screening, referral, diagnosis, treatment, follow-up and survivorship by developing and implementing systems and process change to reduce breast cancer disparities among vulnerable populations. The Vulnerable Populations Grant Program supports projects that: *Implement quality improvement and process improvement strategies to eliminate disparities in screening, care and/or treatment across multiple communities, geographic regions, and/or populations; *Propose implementation of models that seek to improve processes and systems using quality improvement strategies; and *Demonstrate collaboration among stakeholders to develop systems that increase access and utilization of breast health services to all women throughout the breast cancer continuum of care. D - Treatment Many people do not get the breast cancer treatment they need, and as a result, they are less likely to survive. For this reason, Komen supports two treatment assistance programs managed by CancerCare and the Patient Advocate Foundation which aim to connect people with local resources, psychosocial support, and provide critical financial assistance. Both programs, collectively, provide supplementary direct financial help to over 10,000 breast cancer patients for medical co-payments, oral chemotherapy, and other vital care that is related to treatment. In 2013, Komen awarded a $500,000 grant to CancerCare to support the Linking A.R.M.S.(TM) (Assistance & Resources Made Simple) program. Linking A.R.M.S.(TM) is a program dedicated to providing financial assistance, education and support services to low-income, under- or uninsured breast cancer survivors. Funding for Linking A.R.M.S.(TM) provides direct financial assistance to more than 2,100 breast cancer survivors for treatment-related expenses including pain and anti-nausea medication, lymphedema care, oral chemotherapy, durable medical equipment, childcare, and transportation to and from treatment. CancerCare also provides counseling and other support services that enable breast cancer patients to make informed treatment decisions, cope with the emotional effects of the disease, and experience an improved quality of life. In 2012 Komen awarded a $1,500,000, two-year grant to the Patient Advocate Foundation (PAF), a national non-profit organization that assists patients needing help with health-related financial issues. Komen supports PAF's Co-Pay Relief (CPR) program. The CPR program provides direct financial assistance for pharmaceutical co-payments to insured patients with breast cancer, lung cancer and prostate cancer. Komen's funding, along with other key partners, touched more than 10,000 breast cancer patients served through the program over the past two years. For more information about any of the accomplishments described here or to learn more about Susan G. Komen for the Cure, visit www.komen.org or call 1-877 GO KOMEN (1-877-465-6636). Significant Change to governing documents Form 990, Part VI, Question 4 At a meeting of the Board of Directors on May 31, 2012, the Board approved an amendment to the Amended and Restated Bylaws (of June 4, 2010) adding a second, Class III director, increasing the total number of members of the Board of Directors to 10. On November 7, 2012, the Board of Directors approved an amendment to the Bylaws adding a new Board Officer position of Vice Chair. Describe the Process used by Management &/or Governing Body to Review 990 Form 990, Part VI, Question 11b Management prepares the materials for the Form 990, with the assistance and review by external accountants. Senior levels of management review and comment on the final draft of the Form 990 for presentation to the audit committee of the board of directors. The audit committee of the Board of the Directors reviews and approves the Form 990 prior to being filed. Thereafter, each member of the Board of Directors receives an electronic copy of the Form 990 via email prior to the form being filed. Description of Process to Monitor Transactions for Conflicts of Interest Form 990, Part VI, Question 12c Komen produces an annual survey requiring all employees, board members, committee members, and advisory boards to inform on conflicts. Any conflicts are then reviewed by management and the audit committee and appropriate measures are taken. In addition, those same people have the obligation to update the conflict of interest statements during the year. Offices & Positions for Which Process was Used, & Year Process was Begun Form 990, Part VI, Questions 15a and 15b The Compensation Committee of the Board of Directors assists the Board of Komen in overseeing compensation policies and practices. Responsibilities include oversight of the compensation of the President/ Chief Executive Officer, the range of compensation levels for the organization's other officers, disqualified persons, and other employees, granting the CEO authority to determine actual compensation levels within an approved range, and incentive/bonus compensation programs. The current policy was adopted in 2010. A formal Compensation Policy governs pay practices. Periodically, all positions in the organization are reviewed against external market data, engaging independent experts to conduct the benchmarking process. Compensation is then based upon comparable market rates of pay with consideration for internal equity and the financial position of the organization. For the CEO and officers of the organization, external benchmarking was conducted again this fiscal year to ensure market alignment. Salary increases, promotions or other forms of compensation are provided without regard to race, color, religion, gender, national origin, disability, veteran status or sexual orientation. Avail of Gov Docs, Conflict of Interest Policy, & Fin Stmts to Gen Public Form 990, Part VI, Question 19 Komen's financial statements, conflict of interest policy and the 990 are publicly available on our website. The Articles of Incorporation are available from the Texas Secretary of State and other governing documents are made available as required by state law. Form 1023 is not online but available to the public upon request. ADDITIONAL DETAIL ON EVENT PRODUCTION EXPENSES INCLUDED ON OTHER EXP LINE Form 990, Part IX, Line 24 The Susan G. Komen Breast Cancer Foundation, Inc. purchases all T-Shirts for the 136 Races held by the Komen Affiliates during the year. Part X Balance sheet, Line 19 Deferred Revenue from the prior year was reclassified to properly represent the balance. Reconciliation of Net Assets : Part XI, Line 6 In Kind Services - Revenues 10,930,757 In Kind Services - Expenses (11,271,796) Rounding 1 ------------ Total Donated services (341,038) Reconciliation of Net Assets : Part XI, Line 9 Rescinded Grants 3,652,555